Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **D-alanyl-D-alanine terminus of nascent peptidoglycan** is a short peptide motif found at the end of the stem peptide in newly synthesized bacterial peptidoglycan precursors. This motif is critical for **bacterial cell wall synthesis**, as it serves as the recognition site for transpeptidase enzymes that cross-link the peptidoglycan strands, giving the cell wall its mechanical strength and protecting bacteria from osmotic lysis[1][4][7]. Some antibiotics, most notably vancomycin, target this terminus by binding directly and blocking cross-linking, leading to inhibition of cell wall synthesis and bacterial death. Alterations of this terminus, such as D-Ala-D-Lac substitution, confer clinically relevant antibiotic resistance[10]. This motif is therefore a major **therapeutic target** in the treatment of bacterial infections and is implicated in the mechanism of action of several critical antibiotic classes.
Vancomycin and related antibiotics bind directly to the D-Ala-D-Ala terminus, preventing transpeptidase-mediated cross-linking of peptidoglycan and thereby inhibiting cell wall synthesis[10][1]. β-lactam antibiotics mimic the D-Ala-D-Ala structure, irreversibly inactivating transpeptidases that catalyze cross-linking, though they do not directly bind the terminus—rather, they compete at the enzyme’s active site[1].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine terminus of nascent peptidoglycan.